Related Experiment Video
Updated: Jun 16, 2026

Non-invasive Skeletal Muscle Quantification in Small Animals Using Micro-computed Tomography
Published on: November 8, 2024
Artificial intelligence for body composition assessment focusing on sarcopenia
Sachiyo Onishi1, Takamichi Kuwahara2, Masahiro Tajika1
1Department of Endoscopy, Aichi Cancer Center, Nagoya, Aichi, Japan.
Abstract:
This study aimed to address the limitations of conventional methods for measuring skeletal muscle mass for sarcopenia diagnosis by introducing an artificial intelligence (AI) system for direct computed tomography (CT) analysis. The primary focus was on enhancing simplicity, reproducibility, and convenience, and assessing the accuracy and speed of AI compared with conventional methods. A cohort of 3096 cases undergoing CT imaging up to the third lumbar (L3) level between 2011 and 2021 were included. Random division into preprocessing and sarcopenia cohorts was performed, with further random splits into training and validation cohorts for BMI_AI and Body_AI creation. Sarcopenia_AI utilizes the Skeletal Muscle Index (SMI), which is calculated as (total skeletal muscle area at L3)/(height)2. The SMI was conventionally measured twice, with the first as the AI label reference and the second for comparison. Agreement and diagnostic change rates were calculated. Three groups were randomly assigned and 10 images before and after L3 were collected for each case. AI models for body region detection (Deeplabv3) and sarcopenia diagnosis (EfficientNetV2-XL) were trained on a supercomputer, and their abilities and speed per image were evaluated. The conventional method showed a low agreement rate (κ coefficient) of 0.478 for the test cohort and 0.236 for the validation cohort, with diagnostic changes in 43% of cases. Conversely, the AI consistently produced identical results after two measurements. The AI demonstrated robust body region detection ability (intersection over Union (IoU) = 0.93), accurately detecting only the body region in all images. The AI for sarcopenia diagnosis exhibited high accuracy, with a sensitivity of 82.3%, specificity of 98.1%, and a positive predictive value of 89.5%. In conclusion, the reproducibility of the conventional method for sarcopenia diagnosis was low. The developed sarcopenia diagnostic AI, with its high positive predictive value and convenient diagnostic capabilities, is a promising alternative for addressing the shortcomings of conventional approaches.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

